These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24639079)

  • 1. Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in keratinocytes.
    Borland MG; Krishnan P; Lee C; Albrecht PP; Shan W; Bility MT; Marcus CB; Lin JM; Amin S; Gonzalez FJ; Perdew GH; Peters JM
    Carcinogenesis; 2014 Jul; 35(7):1602-12. PubMed ID: 24639079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis.
    Bility MT; Devlin-Durante MK; Blazanin N; Glick AB; Ward JM; Kang BH; Kennett MJ; Gonzalez FJ; Peters JM
    Carcinogenesis; 2008 Dec; 29(12):2406-14. PubMed ID: 18799709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling.
    Zhu B; Ferry CH; Blazanin N; Bility MT; Khozoie C; Kang BH; Glick AB; Gonzalez FJ; Peters JM
    Oncogene; 2014 Nov; 33(46):5348-59. PubMed ID: 24213576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
    Bility MT; Zhu B; Kang BH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2010 Jan; 113(1):27-36. PubMed ID: 19748995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) in Keratinocytes by Endogenous Fatty Acids.
    Zhu B; Zhu X; Borland MG; Ralph DH; Chiaro CR; Krausz KW; Ntambi JM; Glick AB; Patterson AD; Perdew GH; Gonzalez FJ; Peters JM
    Biomolecules; 2024 May; 14(6):. PubMed ID: 38927010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.
    Borland MG; Foreman JE; Girroir EE; Zolfaghari R; Sharma AK; Amin S; Gonzalez FJ; Ross AC; Peters JM
    Mol Pharmacol; 2008 Nov; 74(5):1429-42. PubMed ID: 18687807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).
    Kim DJ; Prabhu KS; Gonzalez FJ; Peters JM
    Carcinogenesis; 2006 May; 27(5):1105-12. PubMed ID: 16418176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.
    Borland MG; Khozoie C; Albrecht PP; Zhu B; Lee C; Lahoti TS; Gonzalez FJ; Peters JM
    Cell Signal; 2011 Dec; 23(12):2039-50. PubMed ID: 21843636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nuclear receptor peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress.
    Zhu B; Ferry CH; Markell LK; Blazanin N; Glick AB; Gonzalez FJ; Peters JM
    J Biol Chem; 2014 Jul; 289(29):20102-19. PubMed ID: 24898257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.
    Koga T; Yao PL; Goudarzi M; Murray IA; Balandaram G; Gonzalez FJ; Perdew GH; Fornace AJ; Peters JM
    J Biol Chem; 2016 Nov; 291(48):25255-25263. PubMed ID: 27765815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2.
    Zhu B; Bai R; Kennett MJ; Kang BH; Gonzalez FJ; Peters JM
    Mol Cancer Ther; 2010 Dec; 9(12):3267-77. PubMed ID: 21159610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins.
    Di-Poï N; Desvergne B; Michalik L; Wahli W
    J Biol Chem; 2005 Nov; 280(46):38700-10. PubMed ID: 16166081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia perturbs aryl hydrocarbon receptor signaling and CYP1A1 expression induced by PCB 126 in human skin and liver-derived cell lines.
    Vorrink SU; Severson PL; Kulak MV; Futscher BW; Domann FE
    Toxicol Appl Pharmacol; 2014 Feb; 274(3):408-16. PubMed ID: 24355420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow cytotoxicity of benzo[a]pyrene is dependent on CYP1B1 but is diminished by Ah receptor-mediated induction of CYP1A1 in liver.
    Galván N; Jaskula-Sztul R; MacWilliams PS; Czuprynski CJ; Jefcoate CR
    Toxicol Appl Pharmacol; 2003 Nov; 193(1):84-96. PubMed ID: 14613719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.
    Balandaram G; Kramer LR; Kang BH; Murray IA; Perdew GH; Gonzalez FJ; Peters JM
    Toxicology; 2016 Jul; 363-364():1-9. PubMed ID: 27427494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin inhibits 7,12-dimethylbenz[a]anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P4501A1/aryl hydrocarbon receptor signaling pathway.
    Maayah ZH; Ghebeh H; Alhaider AA; El-Kadi AO; Soshilov AA; Denison MS; Ansari MA; Korashy HM
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):217-26. PubMed ID: 25697376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4.
    Khozoie C; Borland MG; Zhu B; Baek S; John S; Hager GL; Shah YM; Gonzalez FJ; Peters JM
    BMC Genomics; 2012 Nov; 13():665. PubMed ID: 23176727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure.
    Letavernier E; Perez J; Joye E; Bellocq A; Fouqueray B; Haymann JP; Heudes D; Wahli W; Desvergne B; Baud L
    J Am Soc Nephrol; 2005 Aug; 16(8):2395-402. PubMed ID: 15944338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism.
    Larsen MC; Angus WG; Brake PB; Eltom SE; Sukow KA; Jefcoate CR
    Cancer Res; 1998 Jun; 58(11):2366-74. PubMed ID: 9622076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of CYP1A1 and CYP1B1 in liver and lung by benzo(a)pyrene and 7,12-d imethylbenz(a)anthracene do not affect distribution of polycyclic hydrocarbons to target tissue: role of AhR and CYP1B1 in bone marrow cytotoxicity.
    Galván N; Teske DE; Zhou G; Moorthy B; MacWilliams PS; Czuprynski CJ; Jefcoate CR
    Toxicol Appl Pharmacol; 2005 Feb; 202(3):244-57. PubMed ID: 15667830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.